THE EFFICACY and SAFETY of SUBCUTANEOUS TOCILIZUMAB VERSUS INTRAVENOUS TOCILIZUMAB in COMBINATION WITH TRADITIONAL DMARDS in PATIENTS WITH RA AT WEEK 97 (SUMMACTA)

Página do item simplificado
dc.contributor.authorBurmester, G.
dc.contributor.authorRubbert-Roth, A.
dc.contributor.authorCantagrel, A.
dc.contributor.authorHall, S.
dc.contributor.authorLeszczynski, P.
dc.contributor.authorPollak, Daniel Feldman [UNIFESP]
dc.contributor.authorRangaraj, M. J.
dc.contributor.authorRoane, G.
dc.contributor.authorLudivico, C.
dc.contributor.authorMysler, E.
dc.contributor.authorBennett, M. J.
dc.contributor.authorRowell, L.
dc.contributor.authorBao, M.
dc.contributor.institutionFree Univ Berlin
dc.contributor.institutionHumboldt Univ
dc.contributor.institutionKlinikum Univ Koln
dc.contributor.institutionCtr Hosp Univ Toulouse
dc.contributor.institutionCabrini Med Ctr
dc.contributor.institutionPoznan Med Univ
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionArthrit & Diabet Clin Inc
dc.contributor.institutionRheumatol Associates South Carolina
dc.contributor.institutionEast Penn Rheumatol Associates
dc.contributor.institutionOrg Med Invest
dc.contributor.institutionRoche Prod Ltd
dc.contributor.institutionGenentech Inc
dc.date.accessioned2016-01-24T14:37:20Z
dc.date.available2016-01-24T14:37:20Z
dc.date.issued2014-06-01
dc.description.affiliationFree Univ Berlin, Berlin, Germany
dc.description.affiliationHumboldt Univ, D-10099 Berlin, Germany
dc.description.affiliationKlinikum Univ Koln, Cologne, Germany
dc.description.affiliationCtr Hosp Univ Toulouse, Toulouse, France
dc.description.affiliationCabrini Med Ctr, Malvern, Vic, Australia
dc.description.affiliationPoznan Med Univ, Poznan, Poland
dc.description.affiliationUniversidade Federal de São Paulo, São Paulo, Brazil
dc.description.affiliationArthrit & Diabet Clin Inc, Monroe, LA USA
dc.description.affiliationRheumatol Associates South Carolina, Charleston, SC USA
dc.description.affiliationEast Penn Rheumatol Associates, Bethlehem, PA USA
dc.description.affiliationOrg Med Invest, Buenos Aires, DF, Argentina
dc.description.affiliationRoche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
dc.description.affiliationGenentech Inc, San Francisco, CA 94080 USA
dc.description.affiliationUnifespUniversidade Federal de São Paulo, EPM, São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent499-500
dc.identifierhttp://dx.doi.org/10.1136/annrheumdis-2014-eular.1347
dc.identifier.citationAnnals of the Rheumatic Diseases. London: Bmj Publishing Group, v. 73, p. 499-500, 2014.
dc.identifier.doi10.1136/annrheumdis-2014-eular.1347
dc.identifier.fileWOS000346919802420.pdf
dc.identifier.issn0003-4967
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/37796
dc.identifier.wosWOS:000346919802420
dc.language.isoeng
dc.publisherBmj Publishing Group
dc.relation.ispartofAnnals of the Rheumatic Diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleTHE EFFICACY and SAFETY of SUBCUTANEOUS TOCILIZUMAB VERSUS INTRAVENOUS TOCILIZUMAB in COMBINATION WITH TRADITIONAL DMARDS in PATIENTS WITH RA AT WEEK 97 (SUMMACTA)en
dc.typeinfo:eu-repo/semantics/article
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
WOS000346919802420.pdf
Tamanho:
877.32 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
Coleções
EPM - Outras produções